SCHEMBL5689673

SCHEMBL5689673

Cc1ccccc1OCCN(C)C1CCC(c2ccc(O)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ESR2 Q92731 6/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ESR1 P03372 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HTR7 P34969 1/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689678 1.00 KDM4E (0.45) KDM4EALDH1A1NPSR1ESR2SLC6A2
SCHEMBL5690583 0.85 KDM4E (0.44) KDM4EALDH1A1NPSR1SLC6A2SLC6A4
SCHEMBL5690585 0.85 KDM4E (0.44) KDM4EALDH1A1NPSR1SLC6A2SLC6A4
SCHEMBL5689760 0.84 KDM4E (0.51) KDM4EALDH1A1NPSR1ESR2ESR1
SCHEMBL5689763 0.84 KDM4E (0.51) KDM4EALDH1A1NPSR1ESR2ESR1
SCHEMBL5689617 0.81 KCNH2 (0.46) KDM4EESR2ESR1CYP3A4CYP2C9
SCHEMBL5689429 0.81 KCNH2 (0.46) KDM4EESR2ESR1CYP3A4CYP2C9
SCHEMBL5689433 0.81 KCNH2 (0.46) KDM4EESR2ESR1CYP3A4CYP2C9
SCHEMBL5689510 0.80 CYP3A4 (0.45) KDM4EESR2ESR1CYP3A4CYP2C9
SCHEMBL5689515 0.80 CYP3A4 (0.45) KDM4EESR2ESR1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed